Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00782093
What this trial is testing

Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 63
Post-approval studies (Phase 4)Study completedNCT00680498
What this trial is testing

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment

Who this might be right for
Age-Related Macular Degeneration
Illinois Retina Associates 10
Not applicableEnrolling By InvitationNCT01757132
What this trial is testing

Post-Approval Study of the Implantable Miniature Telescope

Who this might be right for
AMD
VisionCare, Inc. 770
Post-approval studies (Phase 4)Study completedNCT02257632
What this trial is testing

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)UnknownNCT05187104
What this trial is testing

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

Who this might be right for
Age-Related Macular Degeneration
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Testing effectiveness (Phase 2)Study completedNCT03197493
What this trial is testing

Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macula; DegenerationRetina
Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01103505
What this trial is testing

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 1,520
Testing effectiveness (Phase 2)Study completedNCT00413829
What this trial is testing

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 20
Post-approval studies (Phase 4)Study completedNCT01395069
What this trial is testing

Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery

Who this might be right for
Macular Edema
Queen's University 162
Large-scale testing (Phase 3)UnknownNCT01635803
What this trial is testing

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)

Who this might be right for
Retinal Vein Occlusion
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 296
Testing effectiveness (Phase 2)Looking for participantsNCT06942572
What this trial is testing

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy
Splice Bio 57
Not applicableEnded earlyNCT01746875
What this trial is testing

A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes

Who this might be right for
Macular DegenerationRetinal Detachment
Norwegian University of Science and Technology 9
Large-scale testing (Phase 3)Study completedNCT00051129
What this trial is testing

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationMaculopathy, Age-RelatedAge-Related Maculopathies+2 more
Alcon Research 291
Not applicableEnded earlyNCT04658251
What this trial is testing

Study of New Mutations in Cone Disorders

Who this might be right for
Retinal Dystrophy, Cone-RodCone DystrophyCone Rod Dystrophy+1 more
University Hospital, Lille 7
Not applicableStudy completedNCT00787319
What this trial is testing

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Who this might be right for
Age-related Macular Degeneration
Pfizer 108
Not applicableStudy completedNCT03404323
What this trial is testing

"Cataract Surgery in Eyes With Epiretinal Membrane"

Who this might be right for
Epiretinal MembranePseudophakic Cystoid Macular EdemaIrvine-Gass Syndrome+1 more
St John of God Hospital, Vienna 30
Testing effectiveness (Phase 2)Study completedNCT05275205
What this trial is testing

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Who this might be right for
Neovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 51
Post-approval studies (Phase 4)UnknownNCT03468296
What this trial is testing

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Tennessee Retina 22
Not applicableLooking for participantsNCT07005323
What this trial is testing

Progression Suppression and Retinal Regression in VEGF-resistant AMD

Who this might be right for
Neovascular Age-related Macular Degeneration (AMD)
PharmaBio Corporation 10
Early research (Phase 1)WithdrawnNCT01093170
What this trial is testing

A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Mark Kleinman
Next Page